Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peficitinib (ASP015K) in moderate to severe rheumatoid arthritis
NCT01565655Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of peficitinib in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Started Jun 2012; status: completed.
02
Drugs
peficitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01565655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01565655.